Fig. 8

CLR01 treatment reduces tau oligomers in the hippocampus of P301S-tau mice. The soluble fraction from the hippocampus of P301S-tau mice was examined by dot blots probed using the anti-tau-oligomer antibody TOC-1. a Representative dot blots showing the analysis of one mouse from each group in triplicates. b The data were quantified by densitometry and are presented as mean ± SD. P values were calculated using a one-way ANOVA with post hoc Tukey test